Angina clinical trials at UCSF

1 research study open to eligible people

Angina is chest pain that happens when the heart does not get enough blood. UCSF is testing a device that sits in a heart vein for people with hard-to-treat angina. UCSF is checking the device's safety and whether it helps reduce symptoms.

Showing trials for

  • COronary SInus Reducer in Patients With Refractory Angina II

    open to eligible people ages 18 years and up

    To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardial ischemia in the distribution of the left coronary artery and who are deemed unsuitable for revascularization. A non-randomized single-arm registry will further assess the safety and effectiveness of the Shockwave Reducer in selected subjects with reversible myocardial ischemia in the distribution of the right coronary artery and who are deemed unsuitable for revascularization, subjects without documented obstructive coronary disease and abnormal coronary flow reserve (ANOCA), and subjects who cannot complete an exercise tolerance test due to lower limb amputation (above the ankle) or other physiologic condition with documented chronic mobility or balance issues that require the use of a walking aid.

    San Francisco, California and other locations

Our lead scientists for Angina research studies include .

Last updated: